Cargando…
C-Terminal Substitution of MDM2 Interacting Peptides Modulates Binding Affinity by Distinctive Mechanisms
The complex between the proteins MDM2 and p53 is a promising drug target for cancer therapy. The residues 19–26 of p53 have been biochemically and structurally demonstrated to be a most critical region to maintain the association of MDM2 and p53. Variation of the amino acid sequence in this range ob...
Autores principales: | Brown, Christopher J., Dastidar, Shubhra G., Quah, Soo T., Lim, Annie, Chia, Brian, Verma, Chandra S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3164098/ https://www.ncbi.nlm.nih.gov/pubmed/21904608 http://dx.doi.org/10.1371/journal.pone.0024122 |
Ejemplares similares
-
Modulation of p53 binding to MDM2: computational studies reveal important roles of Tyr100
por: Dastidar, Shubhra Ghosh, et al.
Publicado: (2009) -
Structure of a Stapled Peptide Antagonist Bound to Nutlin-Resistant Mdm2
por: Chee, Sharon Min Qi, et al.
Publicado: (2014) -
Assessing the Efficacy of Mdm2/Mdm4-Inhibiting Stapled Peptides Using Cellular Thermal Shift Assays
por: Xiong Tan, Ban, et al.
Publicado: (2015) -
Characterizing the conformational landscape of MDM2-binding p53 peptides using Molecular Dynamics simulations
por: Yadahalli, Shilpa, et al.
Publicado: (2017) -
Rational Optimization of Conformational Effects Induced By Hydrocarbon Staples in Peptides and their Binding Interfaces
por: Lama, Dilraj, et al.
Publicado: (2013)